Table 2.

Characteristics of U.S. Female Adults with NAFLD, NHANES 1988‐2014

Characteristics	1988‐1994 (n = 1,563)		1999‐2006 (n = 993)		2007‐2014 (n = 1,256)
	n	Weighted % ± SEM	n	Weighted % ± SEM	n	Weighted % ± SEM
Age, years†		54.64 ± 0.69		52.73 ± 0.64		51.85 ± 0.46*
Age, %
20‐44	525	32.89 ± 2.49	315	32.05 ± 1.72	383	32.68 ± 1.66
45‐64	504	36.94 ± 2.11	358	40.48 ± 2.04	544	44.67 ± 2.14*
≥65	534	30.17 ± 2.13	320	27.46 ± 1.90	328	22.65 ± 1.40*
RACE, %
non‐Hispanic white	598	72.13 ± 2.72	418	67.54 ± 2.83	492	66.29 ± 2.62
non‐Hispanic black	309	9.76 ± 1.14	135	8.65 ± 1.17	174	8.49 ± 0.98
Hispanic	575	8.88 ± 1.25	415	20.73 ± 2.97*	513	20.98 ± 2.08*
Other	81	9.23 ± 1.94	25	3.08 ± 0.74*	76	4.24 ± 0.75*
Income, %
Low	596	27.22 ± 2.19	307	26.15 ± 2.05	443	27.34 ± 1.43
Middle	595	49.03 ± 2.28	365	37.18 ± 2.31*	421	38.17 ± 1.83*
High	210	23.74 ± 2.86	246	36.67 ± 2.30*	267	34.49 ± 2.44*
Current smoker, %	217	17.45 ± 1.47	142	22.80 ± 1.95*	184	17.86 ± 1.65
BMI		33.22 ± 0.41		34.79 ± 0.36*		35.56 ± 0.22*
HOMA		7.91 ± 0.24		6.46 ± 0.25*		6.52 ± 0.16*
Metabolic components,%
Obesity	981	64.51 ± 2.01	684	72.99 ± 1.97*	918	75.38 ± 1.16*
Type 2 diabetes mellitus	472	26.76 ± 1.71	275	22.80 ± 1.37	388	28.48 ± 1.41*
Hypertension	761	48.16 ± 2.08	588	58.95 ± 1.99*	732	55.94 ± 2.05*
Hyperlipidemia	1,382	89.54 ± 1.25	860	87.98 ± 1.33	1,078	87.73 ± 0.96
Metabolic syndrome	646	40.05 ± 1.84	476	47.52 ± 2.53*	630	49.12 ± 1.64*
Comorbidities, %
Cancer	132	11.45 ± 1.14	105	12.07 ± 1.04	143	13.31 ± 1.54
COPD	146	12.30 ± 1.22	93	12.80 ± 1.43	128	10.72 ± 1.46
CVD	208	11.44 ± 1.21	112	10.53 ± 1.17	137	8.82 ± 0.99
ASCVD ≥7.5%	703	42.69 ± 2.27	409	36.21 ± 1.74*	453	31.61 ± 1.89*
CVD or ASCVD ≥7.5%	746	43.97 ± 2.45	447	38.11 ± 1.86	494	33.12 ± 1.79*

Abbreviation: HOMA, homeostasis model assessment.

^*Significantly different from NHANES III (1988‐1994).

^†Expressed as weighted mean ± SEM.